"Without KidneyCAN, without advocates going to the hill, sitting in front of politicians and telling their stories -- there would not have been any funding for kidney cancer." - Dr. @HHammersMD, UTSW Please take a moment to watch our new video, sharing the KidneyCAN story, and how we're working to accelerate cures for #kidneycancer. Support our work: kidneycan.org/donate-now/ @DrChoueiri @CJSTRAV3 @MikeSerzanMD @advocatekidneys

Tomorrow! 📣 There's still time to register for our FREE Town Hall, Genetics and Kidney Cancer: From Family Risk to the Future of Patient Care. Join us to learn about inherited #KidneyCancer risk, genetic testing, and emerging research that could help shape future care. Bring your questions and stay for our Community Social afterward! Register: kidneycan.org/genetics-kidne… #AcceleratingCures

From understanding inherited risk to exploring new ways to monitor and treat #KidneyCancer, genetics is helping researchers ask important new questions. Join KidneyCAN on October 28 to learn what these discoveries could mean for patients and families, both today and in the future. 📅 5:30–6:30 PM ET | FREE via Zoom Register: kidneycan.org/genetics-kidne… #AcceleratingCures

Clinical trial information can be complicated. Understanding your options shouldn't have to be. Between medical terminology, lengthy study descriptions, and complex eligibility requirements, searching for clinical trials can feel overwhelming. That's where the KidneyCAN Clinical Trial Navigator comes in! Our free, AI-powered tool uses trusted clinical trial databases to help identify potentially relevant kidney cancer studies and make complex information easier to understand. Explore your options today: kidneycan.org/clinical-trial… #AcceleratingCures

Found a potential clinical trial match? Here's what comes next! The KidneyCAN Clinical Trial Navigator makes it easy to save or print your results and bring them to your next doctor's appointment. Use your potential matches to start a conversation with your care team about eligibility, treatment options, and what participating in a clinical trial might involve. Get started with our free, AI-powered tool: kidneycan.org/clinical-trial… #AcceleratingCures

Did you know the @IKCCorg Global Patient Survey on #KidneyCancer is available in 18 languages, gathering experiences from people all around the world? Add your voice today. bit.ly/IKCC_Kidney_Cancer_Gl… #AcceleratingCures

A #KidneyCancer diagnosis can raise questions not just about your own health, but about your family's future. At our upcoming Town Hall, we'll explore what patients and families should know about inherited risk, genetic testing, and new discoveries in kidney cancer research. Join us for this FREE virtual event! Register: kidneycan.org/genetics-kidne… #AcceleratingCures

What role does genetics play in #KidneyCancer? Join us October 28 for a FREE KidneyCAN Town Hall exploring inherited cancer risk, genetic testing, and how emerging research could shape the future of kidney cancer care. Hear from leading experts, get answers to your questions, and connect with our community! 📅 October 28 | 5:30–6:30 PM ET 💻 Free via Zoom Register: kidneycan.org/genetics-kidne… #AcceleratingCures

Not sure where to start when exploring #ClinicalTrials? Finding the right information doesn't have to feel overwhelming! The KidneyCAN Clinical Trial Navigator helps take the guesswork out of your search by using information about your diagnosis, treatment history, and location to identify clinical trials that may be relevant to you. Explore your options with our free, AI-powered tool: kidneycan.org/clinical-trial… #AcceleratingCures

Why are we part of the @IKCCorg Global Patient Survey on #KidneyCancer? When local efforts are coupled with a global approach, we can have the greatest impact on improving health equity and patient outcomes for people affected by kidney cancer. bit.ly/IKCC_Kidney_Cancer_Gl… #AcceleratingCures

If you’re caring for someone living with kidney cancer, this one’s for you. 💙 Tracie knew she couldn't be the only caregiver navigating the challenges of #kidneycancer. When she found an online community, she discovered support, connection, and a sense of belonging that made a lasting impact. Finding that kind of support isn’t always easy. Now, Kompass, a resource built with @kcCURE, @kidneycan, @KidneyCancer, @nkf, & @EisaiUS, helps caregivers find personalized resources, support groups, and other sources of support tailored to their needs. Read Tracie's story and discover resources designed for caregivers on Kompass: kidneycancerkompass.com/

The numbers are in! KidneyCAN Fall Advocacy Days brought together passionate advocates from across the country, all united by one goal: making sure the voices of the #KidneyCancer community are heard on Capitol Hill. Thank you to everyone who participated in Fall Advocacy Days and helped make this effort possible. Together, we're building momentum for a future with better treatments, more research, and better outcomes for people affected by kidney cancer. Our Advocacy Days may be over, but our work continues! 🧡 #AcceleratingCures

Not every clinical trial is right for every patient. That's why finding relevant options starts with understanding more about YOU! The KidneyCAN Clinical Trial Navigator considers several important factors when identifying potential matches, including your diagnosis, your treatment history, your disease characteristics, and your location. Using this information, the Navigator helps identify clinical trials that may be relevant to your specific circumstances, making it easier to explore your options and discuss them with your care team. Ready to see what's out there? kidneycan.org/clinical-trial… #AcceleratingCures

Could #KidneyCancer run in your family? At our October 28 Town Hall, our panelists will discuss hereditary kidney cancer, when genetic testing may be considered, and what patients and families should know about inherited risk. October 28 | 5:30–6:30 PM ET FREE via Zoom Register: kidneycan.org/genetics-kidne… #AcceleratingCures

📢 #KidneyCancer researchers: Don't miss this funding opportunity! The American Association for Cancer Research (AACR) Scholar-in-Training Awards (SITA) will support early-career investigators focused on kidney cancer research, helping them present their work, connect with leading experts, and advance their careers at the 2027 AACR Annual Meeting. 🚨 IMPORTANT: You must apply for AACR Associate Membership by TODAY, October 9, to be eligible! 🔗 Learn more and apply: bit.ly/SITA_2026 #AcceleratingCures

Clinical trials may be available at many different points in the #KidneyCancer treatment journey, including before a patient begins their first systemic treatment. That’s why you don’t have to wait until you’ve run out of options to start learning about clinical trials. Exploring what’s available can help you understand what is being studied and give you more information to discuss with your healthcare team. The KidneyCAN Clinical Trial Navigator makes it easier to explore potential trial options based on your diagnosis, treatment history, and location. Start exploring: kidneycan.org/clinical-trial… #AcceleratingCures

Only about 7% of patients with cancer in the U.S. participate in cancer treatment clinical trials. That matters, not only for the patients who may miss the opportunity to consider a clinical trial, but for the future of cancer care. Low participation can slow research, delay answers to important scientific questions, and make it harder to turn promising discoveries into new treatment options. One piece of the challenge is access. Finding trials that may fit an individual patient can be complicated, especially when trial information and eligibility requirements are difficult to navigate. The KidneyCAN Clinical Trial Navigator was created to make that process easier for people with kidney cancer. The free, AI-powered tool uses information about your diagnosis, treatment history, and location to help identify potential trial matches you can explore and discuss with your healthcare team. Better access to clinical trials can mean more opportunities for patients—and faster progress toward tomorrow’s kidney cancer treatments. Explore the Navigator: kidneycan.org/clinical-trial… #AcceleratingCures